Profile data is unavailable for this security.
About the company
Nanobiotix SA is a France-based nanomedicine company. The Company designs and manufactures nanoparticles that safely enhance the efficacy of radiation therapy in the treatment of cancer. It develops new tools for cancer that utilize a physical mode of action at the cellular level of the cancer cell. The Company's NanoXray technology comprises three products. Local treatment (surgery and radiotherapy) provides potential cure and gives the systemic treatment a better chance to life expectancy. NanoXray products are developed for the efficacy of radiotherapy in the tumor cell. Nanobiotix is a spin-off of the State University of New York (SUNY) at Buffalo.
- Revenue in USD (TTM)-16.31m
- Net income in USD-59.97m
- Incorporated2003
- Employees103.00
- LocationNanobiotix SA60 rue de WattigniesPARIS 75012FranceFRA
- Phone+33 140260470
- Fax+33 140260444
- Websitehttps://www.nanobiotix.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Vir Biotechnology Inc | 68.56m | -437.99m | 1.42bn | 367.00 | -- | 1.62 | -- | 20.76 | -3.16 | -3.16 | 0.4949 | 5.49 | 0.0571 | -- | -- | 186,801.10 | -36.47 | -5.87 | -40.01 | -6.81 | 99.96 | 92.66 | -638.87 | -18.05 | -- | -- | 0.00 | -- | -7.61 | -2.14 | 16.09 | -- | -5.90 | -- |
| AnaptysBio Inc | 169.47m | -84.63m | 1.46bn | 136.00 | -- | -- | -- | 8.63 | -2.82 | -2.82 | 5.70 | -1.07 | 0.4004 | -- | 3.86 | 1,246,081.00 | -19.99 | -19.96 | -22.14 | -21.08 | -- | -- | -49.94 | -200.59 | -- | -- | 1.10 | -- | 432.03 | 62.73 | 11.24 | -- | -14.96 | -- |
| Corvus Pharmaceuticals Inc | 0.00 | -15.08m | 1.47bn | 31.00 | -- | 18.24 | -- | -- | -0.2004 | -0.2004 | 0.00 | 0.961 | 0.00 | -- | -- | 0.00 | -21.65 | -46.71 | -35.55 | -55.72 | -- | -- | -- | -- | -- | -38.28 | 0.00 | -- | -- | -- | -130.47 | -- | -- | -- |
| Nanobiotix SA - ADR | -16.31m | -59.97m | 1.49bn | 103.00 | -- | -- | -- | -- | -1.27 | -1.27 | -0.344 | -1.66 | -0.213 | -- | -- | -151,012.70 | -78.34 | -54.39 | -839.67 | -90.60 | -- | -- | -- | -1,326.20 | -- | -7.32 | -- | -- | -138.62 | -- | -71.62 | -- | -10.10 | -- |
| Nuvation Bio Inc | 26.75m | -217.48m | 1.52bn | 291.00 | -- | 4.59 | -- | 56.66 | -0.6399 | -0.6399 | 0.0787 | 0.9508 | 0.0456 | -- | 6.34 | 121,581.80 | -37.08 | -33.42 | -41.58 | -34.49 | 54.26 | -- | -813.07 | -11,132.31 | 8.39 | -- | 0.3842 | -- | -- | -- | -649.24 | -- | -24.47 | -- |
| Ardelyx Inc | 407.32m | -61.60m | 1.53bn | 489.00 | -- | 9.10 | -- | 3.75 | -0.2576 | -0.2576 | 1.69 | 0.6832 | 0.8691 | 2.03 | 6.29 | 832,965.30 | -13.14 | -27.52 | -15.98 | -35.02 | 90.29 | 87.82 | -15.12 | -42.28 | 4.11 | -2.04 | 0.5485 | -- | 22.09 | 121.90 | -57.40 | -- | 35.72 | -- |
| Sionna Therapeutics Inc | 0.00 | -75.27m | 1.53bn | 59.00 | -- | 4.97 | -- | -- | -1.70 | -1.70 | 0.00 | 6.86 | 0.00 | -- | -- | 0.00 | -29.42 | -- | -30.75 | -- | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -22.01 | -- | -- | -- |
| Iovance Biotherapeutics Inc | 263.50m | -390.98m | 1.54bn | 975.00 | -- | 2.21 | -- | 5.85 | -1.12 | -1.12 | 0.7376 | 1.70 | 0.289 | 3.64 | 3.47 | 270,258.50 | -42.88 | -48.97 | -50.03 | -56.18 | 28.66 | -- | -148.38 | -453.71 | 2.83 | -- | 0.0014 | -- | 60.60 | -- | -5.05 | -- | -6.28 | -- |
| Novavax Inc | 1.12bn | 440.30m | 1.55bn | 749.00 | 3.93 | -- | 3.30 | 1.38 | 2.41 | 2.41 | 6.37 | -0.7858 | 0.821 | 7.20 | 10.46 | 1,499,972.00 | 32.17 | -28.14 | 78.45 | -190.63 | 93.50 | -- | 39.19 | -45.53 | 2.10 | 24.98 | 2.06 | -- | 64.69 | 18.76 | 334.83 | -- | -36.68 | -- |
| Tango Therapeutics Inc | 66.50m | -100.52m | 1.55bn | 155.00 | -- | 8.02 | -- | 23.28 | -0.9208 | -0.9208 | 0.593 | 1.43 | 0.2364 | -- | -- | 429,038.70 | -35.74 | -- | -39.69 | -- | -- | -- | -151.15 | -283.69 | -- | -- | 0.00 | -- | 15.17 | -- | -28.07 | -- | -- | -- |
| Amylyx Pharmaceuticals Inc | 0.00 | -149.28m | 1.55bn | 123.00 | -- | 4.67 | -- | -- | -1.80 | -1.80 | 0.00 | 3.02 | 0.00 | -- | -- | 0.00 | -48.67 | -51.56 | -55.94 | -60.70 | -- | -- | -- | -118.26 | -- | -- | 0.00 | -- | -77.06 | 127.75 | -712.42 | -- | -- | -- |
| Trevi Therapeutics Inc | 0.00 | -45.86m | 1.57bn | 26.00 | -- | 8.28 | -- | -- | -0.3713 | -0.3713 | 0.00 | 1.48 | 0.00 | -- | -- | 0.00 | -34.19 | -45.07 | -36.67 | -51.11 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -64.84 | -- | 31.21 | -- |
| Oruka Therapeutics Inc | 0.00 | -101.63m | 1.59bn | 28.00 | -- | 3.28 | -- | -- | -2.36 | -2.36 | 0.00 | 10.06 | 0.00 | -- | -- | 0.00 | -22.01 | -32.95 | -22.98 | -34.35 | -- | -- | -- | -- | -- | -- | 0.00 | -- | -- | -- | -1,468.16 | -- | 116.21 | -- |
| Biohaven Ltd | 0.00 | -738.82m | 1.60bn | 274.00 | -- | 27.21 | -- | -- | -6.96 | -6.96 | 0.00 | 0.3922 | 0.00 | -- | -- | 0.00 | -138.54 | -125.47 | -185.54 | -162.51 | -- | -- | -- | -- | -- | -- | 0.821 | -- | -- | -- | 12.71 | -- | -23.32 | -- |
| Intellia Therapeutics Inc | 67.67m | -412.69m | 1.61bn | 377.00 | -- | 2.36 | -- | 23.75 | -3.83 | -3.83 | 0.6246 | 5.77 | 0.0666 | -- | 7.53 | 179,498.70 | -40.60 | -35.53 | -45.39 | -39.16 | -- | -- | -609.85 | -872.47 | -- | -- | 0.00 | -- | 16.92 | 3.13 | 20.49 | -- | -20.63 | -- |
Data as of Mar 04 2026. Currency figures normalised to Nanobiotix SA's reporting currency: US Dollar USD
0.16%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Morgan Stanley & Co. International Plcas of 31 Dec 2025 | 22.92k | 0.05% |
| Millennium Management LLCas of 31 Dec 2025 | 16.87k | 0.04% |
| Optiver US LLCas of 31 Dec 2025 | 16.23k | 0.03% |
| Marshall Wace LLPas of 31 Dec 2025 | 9.50k | 0.02% |
| BNP Paribas Financial Marketsas of 31 Dec 2025 | 3.60k | 0.01% |
| RBC Capital Markets LLC (Investment Management)as of 31 Dec 2025 | 2.63k | 0.01% |
| RhumbLine Advisers LPas of 31 Dec 2025 | 2.34k | 0.01% |
| UBS Securities LLCas of 31 Dec 2025 | 1.53k | 0.00% |
| EverSource Wealth Advisors LLCas of 31 Dec 2025 | 514.00 | 0.00% |
| Osaic Wealth, Inc. (Investment Management)as of 31 Dec 2025 | 500.00 | 0.00% |
More ▼
Data from 31 Dec 2025 - 31 Dec 2025Source: FactSet Research Systems Inc.
